Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

NVO submits higher-dose Wegovy to EMA, aiming for greater weight loss and stronger defense against rivals in the obesity ...

The high dose of Wegovy is one part of Novo Nordisk's plan to defend its obesity business, along with a major ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

The U.S. is having its worst year for measles spread in more than three decades, with a total of 1,288 cases nationally and ...

Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...

Novo offers Wegovy doses for $650 per month's supply to patients who cannot get the drug through their insurance coverage, but so far has not followed Lilly in offering its product in vials.

Linda Yaccarino, CEO of Elon Musk-owned social platform X, said on Wednesday she would step down from the top role in a ...

A “click-to-cancel” rule, which would have required businesses to make it easy for consumers to cancel unwanted subscriptions ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Touro University Nevada is asking for volunteers to take part in a study on the long-term effects of injectable weight-loss or diabetic medication.